Esperion Therapeutics
ESPR
$1.90
Share price
-4.52%
Change (1 day)
43.94%
Change (1 year)
Categories
Esperion Therapeutics (ESPR) Fails to deliver data
Key failure to deliver metrics for Esperion Therapeutics:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.51 M
- Last 3 months FTD volume: $3.36 M
- Last year FTD volume: $8.49 M
Failures to deliver for Esperion Therapeutics (ESPR) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Esperion Therapeutics (ESPR) - since 2013
Volume in USD (price x number of shares), data since 2013Esperion Therapeutics (ESPR) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $3.34 M | -50.36% |
| 2023 | $6.74 M | -17.88% |
| 2022 | $8.21 M | -92.54% |
| 2021 | $0.11 B | -22.56% |
| 2020 | $0.14 B | 231.53% |
| 2019 | $42.87 M | -67.65% |
| 2018 | $0.13 B | 186.16% |
| 2017 | $46.31 M | 130.83% |
| 2016 | $20.06 M | -80.53% |
| 2015 | $0.10 B | 663.91% |
| 2014 | $13.49 M | 840.1% |
| 2013 | $1.43 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Pfizer PFE | $31.87 M | $0.32 B | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $59.04 M | $0.14 B | 🇺🇸 USA |
 Ultragenyx RARE | $3.42 M | $16.85 M | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | $14.09 M | $23.42 M | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $1.7 M | $4.65 M | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $2.19 M | $7.77 M | 🇺🇸 USA |